Federal MS therapy panel flawed: MDs

Tuesday, December 7, 2010 - 18:30 in Health & Medicine

The federal panel that rejected the idea of an immediate clinical trial into an experimental vein procedure for Canadians with multiple sclerosis had several deficiencies that should be remedied in future panels, researchers say.

Read the whole article on CBC: Health

More from CBC: Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net